blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP3965823

EP3965823 - USE OF GOLD NANOCLUSTERS IN TREATING HYPERCHOLESTEROLEMIA OR HYPERCHOLESTEROLEMIA-ASSOCIATED DISEASES [Right-click to bookmark this link]
StatusRequest for examination was made
Status updated on  11.02.2022
Database last updated on 12.11.2024
FormerThe international publication has been made
Status updated on  13.11.2020
Most recent event   Tooltip28.05.2024New entry: Renewal fee paid 
Applicant(s)For all designated states
Goldred Nanobiotech Co., Ltd.
9F., No. 111-6, Xiyuan Rd.
Zhongli Dist.
Taoyuan City 320 / TW
For all designated states
Yeh, Hung-i
7F.-1, No. 23 Fushun St.
Zhongshan Dist.
Taipei City, Taiwan 104 / TW
For all designated states
Lee, Yi-Nan
2F., No. 381, Sec. 1 Xinshi 1st Rd.
Tamsui Dist.
New Taipei City, Taiwan 251 / TW
For all designated states
Wang, Hsueh-Hsiao
13F., No. 2, Ln. 21, Sec. 6 Xinhai Rd.
Wenshan Dist.
Taipei City, Taiwan 116 / TW
[2022/11]
Inventor(s)01 / CHANG, Hong-Shong
8F, No.12, Lane 76, Sec.2 Chung-Bei Rd.
Chung-Li Tao-Yuan City, Taiwan 320 / CN
02 / LI, Kuan-Jung
8F., No.5, Ln. 140, Sec. 3 Linsen Rd.
North Dist. Tainan City, Taiwan 704 / CN
03 / LAI, Wei-Chung
11F., No.25 Hongshulin Rd.
Tamsui Dist. New Taipei City, Taiwan 251 / CN
04 / YEH, Hung-i
7F.-1, No. 23 Fushun St.
Zhongshan Dist. Taipei City, Taiwan 104 / CN
05 / LEE, Yi-Nan
2F., No. 381, Sec. 1 Xinshi 1st Rd.
Tamsui Dist. New Taipei City, Taiwan 251 / CN
06 / WANG, Hsueh-Hsiao
13F., No. 2, Ln. 21, Sec. 6 Xinhai Rd.
Wenshan Dist. Taipei City, Taiwan 116 / CN
 [2022/11]
Representative(s)Lang, Christian
LangPatent Anwaltskanzlei IP Law Firm
Ingolstädter Straße 5
80807 München / DE
[2022/11]
Application number, filing date19928273.207.05.2019
[2022/11]
WO2019CN85810
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2020223893
Date:12.11.2020
Language:EN
[2020/46]
Type: A1 Application with search report 
No.:EP3965823
Date:16.03.2022
Language:EN
The application published by WIPO in one of the EPO official languages on 12.11.2020 takes the place of the publication of the European patent application.
[2022/11]
Search report(s)International search report - published on:CN12.11.2020
(Supplementary) European search report - dispatched on:EP14.11.2022
ClassificationIPC:A61K33/242, A61K47/00, A61P3/06, A61K9/00, A61K9/51
[2022/50]
CPC:
A61K9/5115 (EP,US); A61K31/20 (US); A61K33/242 (EP);
A61K47/6923 (EP); A61K47/6929 (EP); A61K9/0019 (EP);
A61P3/06 (EP); B82Y30/00 (EP,US); B82Y40/00 (US);
B82Y5/00 (EP,US) (-)
Former IPC [2022/11]A61K47/00, A61P3/06
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2022/11]
TitleGerman:VERWENDUNG VON GOLDNANOCLUSTERN ZUR BEHANDLUNG VON HYPERCHOLESTERINÄMIE ODER HYPERCHOLESTERINÄMIE-ASSOZIIERTEN ERKRANKUNGEN[2022/11]
English:USE OF GOLD NANOCLUSTERS IN TREATING HYPERCHOLESTEROLEMIA OR HYPERCHOLESTEROLEMIA-ASSOCIATED DISEASES[2022/11]
French:UTILISATION DE NANOAGRÉGATS D'OR DANS LE TRAITEMENT DE L'HYPERCHOLESTÉROLÉMIE OU DE MALADIES ASSOCIÉES À L'HYPERCHOLESTÉROLÉMIE[2022/11]
Entry into regional phase18.11.2021National basic fee paid 
18.11.2021Search fee paid 
18.11.2021Designation fee(s) paid 
18.11.2021Examination fee paid 
Examination procedure18.11.2021Examination requested  [2022/11]
12.06.2023Amendment by applicant (claims and/or description)
Fees paidRenewal fee
18.11.2021Renewal fee patent year 03
20.05.2022Renewal fee patent year 04
31.03.2023Renewal fee patent year 05
27.05.2024Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[E]EP3698787  (MACKAY MEMORIAL HOSPITAL [TW], et al) [E] 1-6,8 * par. 14, 28, 52; claims 2, 6 *;
 [A]  - CHEN HUI ET AL, "Gold nanoparticles improve metabolic profile of mice fed a high-fat diet", JOURNAL OF NANOBIOTECHNOLOGY, vol. 16, no. 1, doi:10.1186/s12951-018-0338-1, (20181201), page 11, URL: https://jnanobiotechnology.biomedcentral.com/counter/pdf/10.1186/s12951-018-0338-1.pdf, XP055977334 [A] 1-8 * abstract; Table 1; supplemental data *

DOI:   http://dx.doi.org/10.1186/s12951-018-0338-1
 [A]  - Ibrahim Ammal Esmaeel, "Effect of Gold Nanoparticles on Serum Lipid Profile in Albino Mice", OnLine Journal of Biological Sciences, (20180401), pages 432 - 434, URL: https://thescipub.com/pdf/ojbsci.2018.432.434.pdf, (20221102), XP055977253 [A] 1-8 * abstract; p. 433, left col., last par.; Table 1 *
International search[X]US9101672  (YEH HUNG-I [TW], et al)[X] 1-19
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.